In silico evidence of direct interaction between statins and β-amyloid

dc.creatorShakour N.
dc.creatorBianconi V.
dc.creatorPirro M.
dc.creatorBarreto G.E.
dc.creatorHadizadeh F.
dc.creatorSahebkar A.
dc.date.accessioned2020-09-02T22:28:12Z
dc.date.accessioned2022-11-08T20:26:53Z
dc.date.available2020-09-02T22:28:12Z
dc.date.available2022-11-08T20:26:53Z
dc.date.created2020-09-02T22:28:12Z
dc.date.issued2019
dc.identifier120, 3, 4710-4715
dc.identifier07302312
dc.identifierhttps://hdl.handle.net/20.500.12728/6241
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5146234
dc.languageen
dc.publisherWiley-Liss Inc.
dc.subjectAlzheimer's disease (AD)
dc.subjectamyloid-β (Aβ)
dc.subjectdocking
dc.subjectstatins
dc.subjectamyloid beta protein
dc.subjectatorvastatin
dc.subjectfluindostatin
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjectmevinolin
dc.subjectpitavastatin
dc.subjectpravastatin
dc.subjectrosuvastatin
dc.subjectsimvastatin
dc.subjectsulindac
dc.subjectamyloid beta protein
dc.subjecthydroxymethylglutaryl coenzyme A reductase inhibitor
dc.subjectArticle
dc.subjectcomputer model
dc.subjectcontrolled study
dc.subjectcrystal structure
dc.subjectdrug protein binding
dc.subjectenzyme active site
dc.subjectmolecular docking
dc.subjectmolecular operating environment software
dc.subjectpriority journal
dc.subjectprotein metabolism
dc.subjectsoftware
dc.subjectAlzheimer disease
dc.subjectchemistry
dc.subjecthuman
dc.subjectmetabolism
dc.subjectmolecular docking
dc.subjectpathology
dc.subjectAlzheimer Disease
dc.subjectAmyloid beta-Peptides
dc.subjectCatalytic Domain
dc.subjectHumans
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectMolecular Docking Simulation
dc.titleIn silico evidence of direct interaction between statins and β-amyloid
dc.typeArticle


Este ítem pertenece a la siguiente institución